A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis-Reference-Cited by-同舟云学术

A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis

Published:2020-05-22 Issue:10 Volume:44 Page:1419-1428
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Fuchs Talia L.,Nassour Anthony J.,Glover Anthony,Sywak Mark S.,Sidhu Stan B.,Delbridge Leigh W.,Clifton-Bligh Roderick J.,Gild Matti L.,Tsang Venessa,Robinson Bruce G.,Clarkson Adele,Sheen Amy,Sioson Loretta,Chou Angela,Gill Anthony J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference46 articles.

1. NRASQ61R mutation-specific immunohistochemistry also identifies the HRASQ61R mutation in medullary thyroid cancer and may have a role in triaging genetic testing for MEN2;Reagh;Am J Surg Pathol,2017

2. Hereditary thyroid cancer syndromes and genetic testing;Rowland;J Surg Oncol,2015

3. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma;Wells;Thyroid,2015

4. Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970;Gharib;Mayo Clin Proc,1992

5. Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986;Girelli;Thyroid,1998

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The road ahead: a brief guide to navigating the 2022 WHO classification of endocrine and neuroendocrine tumours;Journal of Clinical Pathology;2024-07-09

2. Painting the path to precision: unraveling endocrine tumors with immunohistochemistry;Diagnostic Histopathology;2024-06

3. Survival Outcomes of Medullary Thyroid Cancer With and Without Amyloid Deposition;Endocrine Practice;2024-04

4. Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend Regarding the Latest WHO Classification;Biomedicines;2024-03-22

5. Cytologic risk stratification of medullary thyroid carcinoma: Does it make the grade?;Cancer Cytopathology;2024-02-02